GNH USA

Europe — EMA

Melphalan Tillomed

GNH USA supplies Melphalan Tillomed (Melphalan), a alkylating antineoplastic agent for multiple myeloma, ovarian cancer and other solid tumours.

Melphalan

Request sourcing

1
Pack/s

What is Melphalan?

Melphalan, the active ingredient in Melphalan Tillomed, is an alkylating agent presented as a sterile intravenous solution for intravenous use. It treats multiple myeloma, ovarian cancer, malignant melanoma, neuroblastoma and other solid tumours in adult patients. GNH USA supplies Melphalan Tillomed as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, oncology centres and pharmacies worldwide.

What is Melphalan used for?

Melphalan is an alkylating antineoplastic agent used in the treatment of several solid tumours and haematologic malignancies. - Multiple myeloma: induces remission and prolongs survival in eligible patients. - Ovarian cancer: incorporated into combination regimens to reduce tumour burden. - Malignant melanoma: employed in advanced disease to achieve tumour control. - Neuroblastoma: administered as part of high‑risk multimodal therapy. - Other solid tumours: provides cytoreductive effect in selected cases.

What are the side effects of Melphalan?

Adverse reactions are common with alkylating agents and may affect multiple organ systems.

Common Side Effects: - Nausea and vomiting - Bone‑marrow suppression (leukopenia, anemia, thrombocytopenia) - Fatigue - Mucositis

Serious or Rare Side Effects: - Secondary malignancies - Severe infection due to profound neutropenia - Pulmonary toxicity (interstitial pneumonitis or fibrosis)

What precautions apply to Melphalan?

Melphalan requires careful monitoring and specific safety measures before and during therapy. - Blood counts: monitor complete blood count regularly to detect marrow suppression. - Renal function: assess creatinine clearance before each dose. - Hepatic function: evaluate liver enzymes in patients with hepatic impairment. - Hypersensitivity: discontinue if signs of allergic reaction appear. - Contraception: advise effective contraception for both sexes during treatment and for a defined period after. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

What does Melphalan interact with?

Melphalan may interact with other medicines, altering efficacy or toxicity.

Major Interactions (Avoid): - Concurrent use with other alkylating agents: increased myelosuppression. - Live attenuated vaccines: risk of uncontrolled infection. - Strong CYP450 inducers: may reduce plasma concentrations.

Moderate Interactions (Monitor Closely): - NSAIDs: heightened risk of renal toxicity. - Anticoagulants: potential for increased bleeding.

Frequently asked questions

What conditions is Melphalan Tillomed used to treat?+
Melphalan Tillomed is used in the management of multiple myeloma, ovarian cancer, malignant melanoma, neuroblastoma and selected other solid tumours. It is administered as part of chemotherapy protocols designed to control tumour growth and improve patient outcomes.
How does melphalan work as an antineoplastic agent?+
Melphalan belongs to the alkylating agent class. It binds to DNA and creates cross‑links between strands, which blocks DNA replication and transcription. This damage triggers cell‑cycle arrest and apoptosis, especially in rapidly dividing cancer cells.
What is the usual dose of Melphalan Tillomed?+
The dose of Melphalan Tillomed is individualized by the prescribing oncologist based on the specific indication, patient weight, renal function and treatment protocol. Only a qualified healthcare professional should determine the appropriate dosing schedule.
Is Melphalan Tillomed safe to use during pregnancy or breastfeeding?+
Melphalan is classified as contraindicated in pregnancy because it can cause fetal harm. It is also not recommended during breastfeeding, as it may be excreted in milk and affect the infant. Women of child‑bearing potential should use effective contraception throughout treatment and for a period afterward as advised by their physician.
How do I order Melphalan Tillomed from GNH USA?+
To place an order, submit an enquiry on the product page at gnh-usa.com, specifying the required quantity. GNH USA works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including cold‑chain where required) and any necessary import documentation.
How does Melphalan compare with other alkylating agents?+
Melphalan shares the DNA‑alkylating mechanism common to its class, but its pharmacokinetic profile and approved indications differ. Compared with cyclophosphamide, melphalan has a higher potency for certain solid tumours and is often chosen for high‑dose regimens in multiple myeloma, whereas cyclophosphamide is more frequently used in lymphomas and breast cancer.
What are the storage and handling requirements for Melphalan Tillomed?+
Melphalan Tillomed should be stored at 2‑8 °C in a refrigerator, protected from light, and must not be frozen or shaken. The product should be kept in its original packaging until use to maintain stability and sterility.
How is Melphalan Tillomed administered to patients?+
Melphalan Tillomed is administered intravenously by a qualified healthcare professional. The infusion rate and duration are determined by the treatment protocol and patient tolerance, and the drug is typically given in a controlled clinical setting to monitor for immediate reactions.
What are the most serious risks associated with Melphalan Tillomed?+
The most serious risks include severe bone‑marrow suppression leading to life‑threatening infections, secondary malignancies, and pulmonary toxicity such as interstitial pneumonitis. Patients should be closely monitored for signs of infection, respiratory symptoms and any unexpected laboratory abnormalities.
Who should not receive Melphalan Tillomed?+
Melphalan Tillomed is contraindicated in patients with known hypersensitivity to melphalan or any component of the formulation, in those receiving live vaccines, and in pregnant women. Caution is also advised for individuals with severe renal or hepatic impairment, as dose adjustments may be required.
Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.
Send a sourcing enquiry for this product →

Product details

Drug
Melphalan
Route
Intravenous Use
Manufacturer
Tillomed Pharma Gmbh
Origin
EU

Related products

A

A

Liquid Extract From Viscum Album Subsp. Abietis Var Abies Alba (1:20), Extraction Solvents: Water Fo

Helixor Heilmittel Gmbh
EU
A

A

Liquid Extract From Viscum Album Subsp. Abietis Var Abies Alba (1:20), Extraction Solvents: Water Fo

Helixor Heilmittel Gmbh
EU
A

A

Liquid Extract From Viscum Album Subsp. Abietis Var Abies Alba (1:20), Extraction Solvents: Water Fo

Helixor Heilmittel Gmbh
EU
A

A

Liquid Extract From Viscum Album Subsp. Abietis Var Abies Alba (1:20), Extraction Solvents: Water Fo

Helixor Heilmittel Gmbh
EU